Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8552490 | 0.90 | ALDH1A1 (0.42) | ACENPC1RAB9AALDH1A1PKM | |
| SCHEMBL8552104 | 0.89 | ALDH1A1 (0.42) | ACEALDH1A1PKMGAA | |
| SCHEMBL8557349 | 0.83 | L3MBTL1 (0.40) | ACENPC1RAB9AALDH1A1 | |
| SCHEMBL8550015 | 0.81 | ACE (0.38) | ACEALDH1A1GAA | |
| SCHEMBL8557133 | 0.79 | ACE (0.37) | ACEALDH1A1 | |
| SCHEMBL8551020 | 0.78 | ACE (0.43) | ACEALDH1A1 | |
| SCHEMBL8554773 | 0.77 | ALDH1A1 (0.54) | ACEALDH1A1PKMGAA | |
| SCHEMBL8556164 | 0.77 | HDAC3 (0.39) | NPC1RAB9A | |
| SCHEMBL5170081 | 0.74 | GAA (0.42) | ACENPC1RAB9AALDH1A1GAA | |
| SCHEMBL27484036 | 0.74 | ACE (0.40) | ACEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0840725-A1 | AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1998-05-13 | — | — | EP | disclosed |
| WO-1997002242-A1 | AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1997-01-23 | — | — | WO | disclosed |